Baxter International (BAX) Total Non-Current Liabilities (2009 - 2026)
Baxter International (BAX) posted quarterly Total Non-Current Liabilities of $12.4 billion for Q2 2026, down 1.91% year-over-year from $12.7 billion in Q2 2025, and down 0.99% quarter-over-quarter from $12.5 billion in Q1 2026.
Baxter International (BAX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Total Non-Current Liabilities for 18 consecutive years, with $12.4 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 1.91% year-over-year to $12.4 billion; the TTM figure through Jun 2026 stood at $12.4 billion (down 1.91% YoY), while the FY2025 annual figure was $12.7 billion, down 28.37% from the prior year.
- Total Non-Current Liabilities retreated to $12.4 billion in Q2 2026 per BAX's latest filing, from $12.5 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $21.2 billion in Q1 2022 and bottomed at $12.4 billion in Q2 2026.
- Historically, Total Non-Current Liabilities has averaged $17.2 billion across 5 years, with a median of $17.8 billion in 2024.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities jumped 126.58% — and 2025, when it declined 28.37%.
- Baxter International's Total Non-Current Liabilities stood at $20.5 billion in 2022, then retreated by 10.4% to $18.4 billion in 2023, then dropped by 3.94% to $17.7 billion in 2024, then slipped by 28.37% to $12.7 billion in 2025, then decreased by 1.99% to $12.4 billion in 2026.
- Business Quant data shows BAX's Total Non-Current Liabilities at $12.4 billion in Q2 2026, $12.5 billion in Q1 2026, and $12.7 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 2.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.41 Bn |
| Mar 31, 2026 | 12.54 Bn |
| Dec 31, 2025 | 12.67 Bn |
| Sep 30, 2025 | 12.73 Bn |
| Jun 30, 2025 | 12.66 Bn |
| Mar 31, 2025 | 13.13 Bn |
| Dec 31, 2024 | 17.68 Bn |
| Sep 30, 2024 | 17.47 Bn |
| Jun 30, 2024 | 17.01 Bn |
| Mar 31, 2024 | 17.90 Bn |
| Dec 31, 2023 | 18.41 Bn |
| Sep 30, 2023 | 20.71 Bn |
| Jun 30, 2023 | 20.63 Bn |
| Mar 31, 2023 | 20.50 Bn |
| Dec 31, 2022 | 20.54 Bn |
| Sep 30, 2022 | 20.32 Bn |
| Jun 30, 2022 | 20.66 Bn |
| Mar 31, 2022 | 21.16 Bn |
| Dec 31, 2021 | 21.91 Bn |
| Sep 30, 2021 | 9.37 Bn |